FDA Adverse Event Malfunction Summary report: N

REAGENT RED BLOOD CELLS BIOTESTCELL 3

MDR report key: 2572201 · Received May 14, 2012

Report

Report Number
9610824-2012-00069
Event Type
Malfunction
Date Received
May 14, 2012
Date of Event
April 16, 2012
Report Date
May 14, 2012
Manufacturer
BIO-RAD MEDICAL DIAGNOSTICS GMBH
Product Code
KSZ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THIS IS OUR COMBINED INITIAL AND FINAL REPORT ON THIS INCIDENT.

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT CELL #1 OF BIOTESTCELL 3 YIELDED FALSE POSITIVE ANTIBODY SCREENING TEST RESULTS IN THE ORTHO GEL SYSTEM. THE CUSTOMER SAID THAT THIS WAS AN ONGOING PROBLEM, BUT SHE WAS NOT ABLE TO PROVIDE THE PRECISE DATE WHEN THE PROBLEM OCCURED. THE LAST OCCURRENCE WAS ON OUR STATED DATE OF EVENT, ON (B)(6) 2012. THE PATIENT SAMPLE THAT HAD CAUSED THE FALSE NEGATIVE RESULT WAS SENT TO US FOR QUALITY CONTROL AND THE SUPPOSEDLY DEFECTIVE PRODUCT WAS RETURNED, TOO. OUR QUALITY CONTROL LABORATORY RETESTED THE ALLEGEDLY DEFECTIVE SAMPLE OF BIOTESTCELL 3 WITH THE PATIENT SAMPLES IN SOLIDSCREEN II ON TANGO AND IN THE 3- PHASE TUBE TECHNIQUE. ONLY ONE OF THE TWO PATIENT SAMPLES, SAMPLE #1, YIELDED A WEAK POSITIVE REACTION IN THE INDIRECT ANTIHUMAN GLOBULIN TEST IN TUBE WITH CELL #1 OF BIOTESTCELL #1. FURTHERMORE, PATIENT SAMPLE #1 WAS TESTED IN TUBE TECHNIQUE WITH AN INCUBATION AT 4°C IN COLD. PATIENT SAMPLE #1 REACTED WITH ALL THREE SCREENING CELLS WEAK POSITIVELY. THE RETAINED SAMPLE OF BIOTESTCELL 3 WAS TESTED WITH DIFFERENT POSITIVE AND NEGATIVE SAMPLES ALL POSITIVE AND NEGATIVE REACTIONS WERE CORRECT. WE DID NOT OBSERVE ANY FALSE POSITIVE REACTIONS. THE GEL CARD SYSTEM IS NOT SUITABLE FOR THE CUSTOMER´S INTENDED APPLICATION: DETECTION OF UNEXPECTED ANTIBODIES. IN THIS CASE, WE RECOMMEND THE TUBE TEST OR SOLID PHASE TEST SOLIDSCREEN II WITH TANGO OPTIMO. TESTING BY OUR QUALITY CONTROL LABORATORY CONFIRMED THE ALLEGEDLY DEFECTIVE LOT OF BIOTESTCELL 3 FUNCTIONS CORRECTLY. THE POSITIVE REACTION OF PATIENT SAMPLE #1 WAS CAUSED BY AN COLD REACTING ANTIBODY. A REVIEW OF THE BATCH RECORD DOCUMENTATION SHOWED NO IRREGULARITIES WHICH MIGHT HAVE NEGATIVELY AFFECTED THE QUALITY OF THE ALLEGEDLY DEFECTIVE LOT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 REAGENT RED BLOOD CELLS BIOTESTCELL 3 BIOTESTCELL 3 KSZ BIO-RAD MEDICAL DIAGNOSTICS GMBH 8211021

Patients

Seq Age Sex Outcome Treatment
1 ORTHO GEL PANEL: LOT RC393